Pseudomonas aeruginosa isolated from adult bronchiectasis patients
As one of the ESKAPE pathogens, P. aeruginosa is recognised globally as a serious concern for public health, primarily due to its virulence, multidrug (MDR) and pandrug resistance potential, and association with poor clinical outcomes. Compared to international cohorts, our understanding of P. aeruginosa infections in Australians with bronchiectasis is relatively poor, with very little known about population diversity, antimicrobial resistance (AMR), or persistence and transmission dynamics. We aimed to help resolve this knowledge gap